Biotech · Private company
Momenta Pharmaceuticals, Inc.
Track this companyFree. Adds Momenta Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Biological: M254Phase 2 · Immune Thrombocytopenic Purpura (ITP)ClinicalTrials.gov · fetched Nov 12, 2026
- Intravenous immunoglobulin (IVIg)Phase 2 · Immune Thrombocytopenic Purpura (ITP)ClinicalTrials.gov · fetched Nov 12, 2026
- M118Phase 2 · Coronary Artery Disease (CAD)ClinicalTrials.gov · fetched Nov 12, 2026
- M281Phase 2 · Generalized Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- Unfractionated HeparinPhase 2 · Coronary Artery Disease (CAD)ClinicalTrials.gov · fetched Nov 12, 2026
- M923Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia GravisPHASE2 · TERMINATED · started Aug 6, 2019ClinicalTrials.gov NCT03896295 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia GravisPHASE2 · COMPLETED · started Apr 10, 2019ClinicalTrials.gov NCT03772587 · fetched Nov 12, 2026
- Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) PatientsPHASE1_PHASE2 · TERMINATED · started Dec 21, 2018ClinicalTrials.gov NCT03866577 · fetched Nov 12, 2026
- Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)PHASE3 · COMPLETED · started Aug 23, 2018ClinicalTrials.gov NCT03610646 · fetched Nov 12, 2026
- Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy SubjectsPHASE1 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02675023 · fetched Nov 12, 2026
- Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)PHASE2 · COMPLETED · started Sep 1, 2007ClinicalTrials.gov NCT00543400 · fetched Nov 12, 2026